Objectives Historically, the neonatal Bacillus Calmette-Guérin (BCG) vaccination, was
offered to patients considered to be at high risk of coming into contact with tuberculosis (TB) …

Aim The development of effective antibiotics and the BCG vaccination has significantly
reduced the number of TB cases. The aim of this quality improvement project (QIP) is to …

Background Recent reports indicate an ongoing BCG shortage that may influence
immunisation practice. This study aimed to determine current availability of BCG vaccine …

Introduction The introduction of a national evaluation of newborn screening for Severe
Combined Immunodeficiency (SCID) in England triggered a change to the selective Bacillus …

Background and aims Bacillus Calmette-Guérin (BCG) vaccination is the most commonly
given vaccine in human history. A small proportion of infants receiving it develop adverse …

Background Universal BCG vaccination in the UK ended in 2005. The new vaccination
policy instead offers a number of different forms of selective vaccination to newborns based …

Abstract Background The Neonatal BCG Immunisation programme is a key part of
tuberculosis (TB) control efforts in the UK; however, there is considerable variability in the …

Immunisation is one of the most important and effective strategies in public health. 1 A
nationally funded National Immunisation Program schedule, combined with the Australian …

In March 2017, the National Institute for Health and Care Excellence published updated
quality standards for the UK, aimed at increasing vaccine uptake and coverage and …

Methods Funding was obtained from Barnet and Camden Primary Care Trusts and senior
RFH staff supported development of the service. Trust policies, guidelines and checklists …